Cancer Information Center

Background and Miscellaneous Information

Information from reputable sources, such as the National Cancer Institute, AHCPR, etc.

Information about Specific Types of Cancer

Access information on PharmInfoNet and elsewhere on specific types of cancer.

Articles

An archive of articles from publications such as the Medical Sciences Bulletin, PNN Pharmacotherapy Line, etc.

Drugs Used in the Treatment of Cancer

Links to entries in DrugDB, our acclaimed database of information about specific drugs.

Other Sources of Information

Links to Websites and other Internet resources for cancer information, including newsgroups, email lists, and web sites.

Return to top...

Return to top...

• Viadur Approved for Treatment of Advanced Prostate Cancer
  - prof'l version; 27 Mar 2000
• Viadur Approved for Treatment of Advanced Prostate Cancer
  - consumer version; 27 Mar 2000
• First Clinical Study of Triapine Completed in Cancer Patients
  - prof'l version; 27 Mar 2000
• First Clinical Study of Triapine Completed in Cancer Patients
  - consumer version; 27 Mar 2000
• SU5416 Inhibits Growth and Spread of Colorectal Cancer, Early Study Shows
  - prof'l version; 19 June 2000
• SU5416 Inhibits Growth and Spread of Colorectal Cancer, Early Study Shows
  - consumer version; 19 June 2000
• Clinical Trials Show Genasense May Enhance Efficacy of Anticancer Drugs
  - prof'l version; 19 June 2000
• Clinical Trials Show Genasense May Enhance Effectiveness of Anticancer Drugs
  - consumer version; 19 June 2000
• Study Supports Promise of Cobra-1, the First in a New Class of Anticancer Drugs - prof'l version; 17 July 2000
• Study Supports Promise of Cobra-1, the First in a New Class of Anticancer Drugs - consumer version; 17 July 2000

Med-Brief

• Approval of drug treatment for relapsed small cell lung cancer - Jan 99
• Drug maintains remission in patients with non-Hodgkin's lymphoma - Jan 99
• Drug Treatment of Advanced Colorectal Cancer - Nov 98
• Drug treatment for infertility and the risk of ovarian cancer - Jan 99
• Flutamide and Surgical Removal of Testes: Effect on Survival Rate of Metastatic Prostate Cancer Patients - Oct 98
• Is Hormone Replacement Therapy Effective in Reducing the Risk of Some Cancers? - Oct 98
• Plant Extract Eases Benign Prostatic Hyperplasia Symptoms - Nov 98
• Possible use of diabetes drug for the treatment of liposarcoma - Apr 99
• Post-castration Drug Therapy in Advanced Prostate Cancer Patients - Nov 98
• Side-effects of the breast cancer drug tamoxifen - Feb 99
• Tamoxifen Approved for Breast Cancer Risk Reduction - Nov 98
• U.S. availability of drug therapy for breakthrough cancer pain - Apr 98

Medical Sciences Bulletin

• Beta Carotene and Vitamin A Halted in Lung Cancer Prevention Trial
• Calcium Channel Blockers and Cancer
• Cytoprotectant Amifostine Approved
• Debate Over Ifosfamide
• Dolasetron for Chemotherapy-induced Nausea
• Edatrexate
• Estrogens and Risk of Breast Cancer
• Etoposide for Non-Hodgkin's Lymphoma in the Elderly
• FDA Expands Access to Experimental Treatment for Advanced Renal Cell Cancer
• Focus On... Cancer: Trends in Treatment and Prevention
• Focus On... The Prostate
• Gemcitabine Approved for Pancreatic Cancer
• Granisetron Approved for Chemotherapy- induced Vomiting
• Hair Dyes and Cancer Risk
• Homing In on Cancer Cells
• Hope for Smokers who Want to Quit
• IL-2 Antibody Impairs Leukemia-free Survival in GVHD Prophylaxis
• Induced Abortion and Breast Cancer: The Scientific Evidence
• Irinotecan Approved for Advanced Colorectal Cancer
• Letrozole for Breast Cancer
• Liposomal Daunorubicin for KS
• Liposomal-entrapped Doxorubicin for AIDS- related Kaposi's Sarcoma
• Low-dose IFN-alpha as Effective as High- dose for Chronic Myeloid Leukemia
• Molecule of the Year: p53
• NIH Clinical Alert: Adjuvant Therapy of Breast Cancer - Tamoxifen Update
• Nilutamide and Mitoxantrone Approved for Prostate Cancer
• Oral Granisetron Antiemetic for High-dose Chemotherapy
• Oral Ondansetron Indication Expanded to Post-Op Nausea and Vomiting
• Oral Pilocarpine Hydrochloride for Radiation-induced Dry Mouth
• Paclitaxel Plus Carboplatin Shows Promise in Advanced NSCLC
• Perflubrons
• Pegasparagase Approved for Acute Lymphoblastic Leukemia
• Photofrin Recommended as Palliative for Esophageal Cancer
• Porfimer: A Novel Approach to the Management of in situ Cancers
• Porfimer Approved for Esophageal Cancer Obstructions
• Rituximab for Refractory Non-Hodgkin's Lymphoma
• Secondary Smoke
• Semisynthetic Taxol Approved for Breast, Ovarian Cancer
• Soy Protein May Protect Against Breast Cancer
• Sunscreens and Melanoma
• Tamsulosin for Benign Prostatic Hyperplasia
• Terazosin Receives Expanded Marketing Approval for Benign Prostatic Hypertrophy
• The Tamoxifen Trials
• Topotecan Approved for Ovarian Cancer
• Toremifene for Metastatic Breast Cancer in Postmenopausal Women
• Tretinoin (Vesanoid) for promyelocytic leukemia
• Vinorelbine Recommended for Non- Small-Cell Lung Cancer
• Vinorelbine Approved for Advanced Lung Cancer
• Vitamin Supplements: Word from China
• Wok Cooking and Lung Cancer Risk
• Zoladex Approval for Advanced Breast Cancer

PNN Pharmacotherapy Line

• AMA Cancer Symposium: New Biotherapeutic Agents
• American Society of Hematology Update
• Ara-C with Interferon Improves CML Survival
• Breast CA: Detect Early, Treat Conservatively
• Breast Cancer Symposium Opens in San Antonio
• Cancer Mortality Rates Falling in U.S.
• CCBs: No Link to Cancer
• Dolasetron Approved
• Drug Combo Promising in Advanced Cancers
• FDA Approves Rituximab and Zolmitriptan
• High-Dose Chemo: Watch the Nausea, But Exercise!
• JAMA Highlights Cancer
• Light-Activated Porfimer Approved for Lung Cancer
• Maintenance Chemotherapy: No Benefit in Breast CA
• Medical Marijuana: Some Usefulness
• New Research on Cancer Genes
• Tamoxifen: Worth the Risk for Prevention of Breast Cancer in High-Risk Women
• Treatments Explored for Advanced Colorectal CA

AHCPR Research Activities

• PSA testing for early detection of prostate cancer provides little useful information in men with BPH

• More prevalent severe obesity may explain black/white difference in stage at diagnosis of breast cancer

Drugs for Treating Cancer

• bleomycin
• docetaxel (Taxotere)
• doxorubicin
• edatrexate
• etoposide
• finasteride (Proscar)
• flutamide (Eulexin)
• gemcitabine (Gemzar)
• goserelin acetate (Zoladex)
• granisetron (Kytril)
• irinotecan (Campto/Camptosar)
• leuprolide (Viadur)
• methotrexate
• ondansetron (Zofran)
• paclitaxel (Taxol)
• pegaspargase (Oncaspar)
• pilocarpine hydrochloride (Salagen)
• porfimer sodium (Photofrin)
• interleukin-2 (Proleukin)
• rituximab (Rituxan)
• topotecan (Hycamtin)
• trastuzumab (Herceptin)
• tretinoin (Retin-A)
• Triapine
• vincristine
• vinorelbine tartrate (Navelbine)

THE CANCER FAQ

An evolving resource of online information about cancer.

TO AUTOMATICALLY RECEIVE THIS LIST: Send an email to listserv@sjuvm.stjohns.edu and have 1 line in the message body: afd add cancer faq

Maintainer: E. Loren Buhle, Jr. Ph.D.
Email: BUHLEL01@MCRCR6.MED.NYU.EDU

Web Sites

Government Sources

NCI PDQ

International Cancer Information Center (NCI)

The National Cancer Institute

Cancer Incidence and Mortality by Race/Ethnicity in California, 1988-1991

International Agency for Research on Cancer

US Dept of Toxic Subtances and Disease Registry (ATSDR): carcinogens

Educational Institution Sources

Stanford University Division of Oncology

The Fred Hutchinson Cancer Research Center

Pediatric Bone Marrow Transplant Program at Unviersity of Nebraska

Fox Chase Cancer Center

OncoLink, U. of Pennsylvania

Quick Information about Cancer for Patients and their Families

Le Journal du Cancer

Sloan-Kettering Cancer Center (New York)

Thomas Jefferson Cancer Center (Philadelphia)

Hypermedia Clinical Practice Guidelines for Cancer Pain

The University of Texas M. D. Anderson Cancer Center

The University of Liverpool CRC Oncology Research Unit

H. Lee Moffitt Cancer Center Home Page

NYU Kaplan Comprehensive Cancer Center

University of Michigan Comp. Cancer Center

Last modified on 07/04/99 02:22:00 PM.

© 1998 VirSci Corporation. All rights reserved. As seen on PharmInfoNet ()